Lambda Canada | Bioanalytical Services
7369
page-template-default,page,page-id-7369,page-child,parent-pageid-7313,ajax_fade,page_not_loaded,,qode-theme-ver-3.6,wpb-js-composer js-comp-ver-5.2,vc_responsive

Bioanalytical Services

Infrastructure

State-of-the-art LC/MS-MS Instrumentation:

  • 12 LC/MS-MS systems on site with access to 40+ globally
  • 4 AB SCIEX 6500/6500+
  • 6 TSQs
  • 2 Waters QPXE

Capabilities

  • 800+ validated methods ( incl. methods as low as 1pg /ml) and approximately 3-4 new methods validated every month
  • Capacity to analyze 15,000+ samples/month
  • Method development/validation for proprietary (NCE) and non-proprietary assays
  • Method transfer or cross validation between global sites, instruments, species & matrices
  • Methods for drug-drug interaction studies and cocktail assays
  • Bioanalysis of drug and metabolites in a variety of biological matrices from preclinical and clinical trials
  • Ability to develop and validate highly sensitive assays in low pg/mL range
  • Ability to develop and validate methods well in advance based on patent expiry and business sense
  • Ability to accommodate projects with rapid turn-around-times
  • Qualified, trained & experienced team of bioanalytical professionals

Sample Storage

All study samples are stored at -25±5°C, -70±10°C in secure freezers, controlled and continuously monitored and supported by a standby generator & UPS (Uninterrupted Power Supply) system.